Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:57:57.711Z.
Calculation as of: 2026-10-06T16:57:57.711Z.
Quote observation: 2026-10-06T16:49:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b1195b951add05ab4c37664b10382d427b1d38f05de7a164f71fe4d518fffb76
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
ProMIS Neurosciences, Inc.
Market Cap
$83.53M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.62M
Free Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$84.13M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.69M
Free Cash Flow Yield
N/A
TTM Avg
0.90%
3Y Avg
0.90%
5Y Avg
0.90%
Market Cap
$81.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.40M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProMIS Neurosciences, Inc. (PMN) | $83.53M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.62M | N/A | 5.92% | 6.70% | 6.29% |
| Humacyte, Inc. (HUMA)vs › | $84.07M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | N/A | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.41M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.69M | N/A | 0.90% | 0.90% | 0.90% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $81.97M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.40M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $79.87M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.04M | N/A | 0.15% | 0.15% | 0.15% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
